Effects of glucagon-like peptide-1 analogue and fibroblast growth factor 21 combination on the atherosclerosis-related process in a type 2 diabetes mouse model
Several critical questions remain unresolved: (1) most existing studies are confined to animal and cellular models, with a notable lack of large-scale population-based investigations and clinical validation, thereby impeding translational application
Precautions Some people need to be extra careful: People who have asthma People with liver or kidney diseases Pregnant or breastfeeding women People with organ transplants Qualified doctors should only administer glutathione by IV or intramuscular injection
doi: 10.3390/jcm13082176
The majority of current users have a primary diagnosis of type 2 diabetes, while a growing proportion are using these medications primarily for weight management
Maiorino M, Conrad M, Ursini F (2018) GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues